
Shoulder & Elbow
Superior clinical and structural outcome not observed with PRFM augmentation in RC repair
This report has been verified
by one or more authors of the
original publication.
Am J Sports Med. 2011 Feb;39(2):258-65. doi: 10.1177/0363546510390780. Epub 2010 Dec 15
88 patients were randomized to determine the effect of repair augmented with platelet-rich fibrin matrix (PRFM) membrane in the treatment of rotator cuff tear. Patients were allocated to either surgery with PRFM sutured into the repair site, or non-augmented repair. Follow-up was conducted for a minimum of 16 months postoperatively for clinical and radiographic outcomes. Results at final follow-up indicated that there was no significant difference between groups in Constant score, tendon thickness, or size of the tendon footprint, although the tendon signal intensity was graded higher in the PRFM-augmented group. Routine use of PRFM in rotator cuff repair was not supported by the findings of this research.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.